Gregory Cote to Protein Kinase Inhibitors
This is a "connection" page, showing publications Gregory Cote has written about Protein Kinase Inhibitors.
Connection Strength
0.200
-
NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function. Br J Pharmacol. 2016 Feb; 173(3):613-26.
Score: 0.104
-
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. BMC Cancer. 2014 Sep 19; 14:681.
Score: 0.095